nodes	percent_of_prediction	percent_of_DWPC	metapath
Bedaquiline—CYP3A4—Topotecan—lung cancer	0.0961	0.142	CbGbCtD
Bedaquiline—CYP3A4—Gefitinib—lung cancer	0.0879	0.13	CbGbCtD
Bedaquiline—CYP3A4—Teniposide—lung cancer	0.0852	0.126	CbGbCtD
Bedaquiline—CYP3A4—Vinorelbine—lung cancer	0.0677	0.1	CbGbCtD
Bedaquiline—CYP3A4—Crizotinib—lung cancer	0.0539	0.0796	CbGbCtD
Bedaquiline—CYP3A4—Erlotinib—lung cancer	0.052	0.0768	CbGbCtD
Bedaquiline—CYP3A4—Paclitaxel—lung cancer	0.0476	0.0703	CbGbCtD
Bedaquiline—CYP3A4—Irinotecan—lung cancer	0.0469	0.0694	CbGbCtD
Bedaquiline—CYP3A4—Vinblastine—lung cancer	0.0417	0.0617	CbGbCtD
Bedaquiline—CYP3A4—Etoposide—lung cancer	0.0376	0.0556	CbGbCtD
Bedaquiline—CYP3A4—Docetaxel—lung cancer	0.0344	0.0508	CbGbCtD
Bedaquiline—CYP3A4—Doxorubicin—lung cancer	0.0256	0.0379	CbGbCtD
Bedaquiline—Musculoskeletal discomfort—Pemetrexed—lung cancer	0.00141	0.00459	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Topotecan—lung cancer	0.00138	0.00448	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Erlotinib—lung cancer	0.00137	0.00444	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Irinotecan—lung cancer	0.00137	0.00443	CcSEcCtD
Bedaquiline—Decreased appetite—Pemetrexed—lung cancer	0.00135	0.00438	CcSEcCtD
Bedaquiline—Decreased appetite—Gefitinib—lung cancer	0.00134	0.00435	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Pemetrexed—lung cancer	0.00134	0.00435	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Gefitinib—lung cancer	0.00133	0.00432	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Gemcitabine—lung cancer	0.00133	0.00431	CcSEcCtD
Bedaquiline—Chest pain—Teniposide—lung cancer	0.00131	0.00426	CcSEcCtD
Bedaquiline—Transaminases increased—Doxorubicin—lung cancer	0.00131	0.00424	CcSEcCtD
Bedaquiline—Hepatitis—Erlotinib—lung cancer	0.0013	0.00421	CcSEcCtD
Bedaquiline—Connective tissue disorder—Erlotinib—lung cancer	0.00128	0.00414	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Cisplatin—lung cancer	0.00124	0.00402	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Irinotecan—lung cancer	0.0012	0.00391	CcSEcCtD
Bedaquiline—Anorexia—Teniposide—lung cancer	0.0012	0.00389	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Vinorelbine—lung cancer	0.00118	0.00384	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Gemcitabine—lung cancer	0.00117	0.00381	CcSEcCtD
Bedaquiline—Diarrhoea—Crizotinib—lung cancer	0.00116	0.00377	CcSEcCtD
Bedaquiline—Arrhythmia—Erlotinib—lung cancer	0.00116	0.00376	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Gemcitabine—lung cancer	0.00115	0.00373	CcSEcCtD
Bedaquiline—Dizziness—Crizotinib—lung cancer	0.00112	0.00364	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Paclitaxel—lung cancer	0.00111	0.00361	CcSEcCtD
Bedaquiline—Connective tissue disorder—Vinorelbine—lung cancer	0.0011	0.00358	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Cisplatin—lung cancer	0.00109	0.00355	CcSEcCtD
Bedaquiline—Decreased appetite—Teniposide—lung cancer	0.00109	0.00355	CcSEcCtD
Bedaquiline—Vomiting—Crizotinib—lung cancer	0.00108	0.0035	CcSEcCtD
Bedaquiline—Haemoptysis—Doxorubicin—lung cancer	0.00107	0.00349	CcSEcCtD
Bedaquiline—Rash—Crizotinib—lung cancer	0.00107	0.00347	CcSEcCtD
Bedaquiline—Dermatitis—Crizotinib—lung cancer	0.00107	0.00347	CcSEcCtD
Bedaquiline—Diarrhoea—Pemetrexed—lung cancer	0.00106	0.00345	CcSEcCtD
Bedaquiline—Toremifene—CYP1A1—lung cancer	0.00106	0.249	CrCbGaD
Bedaquiline—Diarrhoea—Gefitinib—lung cancer	0.00106	0.00342	CcSEcCtD
Bedaquiline—Cardiac disorder—Vinorelbine—lung cancer	0.00104	0.00338	CcSEcCtD
Bedaquiline—Dizziness—Pemetrexed—lung cancer	0.00103	0.00333	CcSEcCtD
Bedaquiline—Nausea—Crizotinib—lung cancer	0.00101	0.00327	CcSEcCtD
Bedaquiline—CYP3A4—Felbamate Metabolism—CYP2E1—lung cancer	0.00101	0.0907	CbGpPWpGaD
Bedaquiline—Arrhythmia—Vinorelbine—lung cancer	0.001	0.00325	CcSEcCtD
Bedaquiline—Vomiting—Pemetrexed—lung cancer	0.000987	0.0032	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Paclitaxel—lung cancer	0.000983	0.00319	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Etoposide—lung cancer	0.000982	0.00318	CcSEcCtD
Bedaquiline—Vomiting—Gefitinib—lung cancer	0.000981	0.00318	CcSEcCtD
Bedaquiline—Rash—Pemetrexed—lung cancer	0.000979	0.00318	CcSEcCtD
Bedaquiline—Dermatitis—Pemetrexed—lung cancer	0.000978	0.00317	CcSEcCtD
Bedaquiline—Rash—Gefitinib—lung cancer	0.000973	0.00316	CcSEcCtD
Bedaquiline—Myalgia—Topotecan—lung cancer	0.000972	0.00315	CcSEcCtD
Bedaquiline—Arthralgia—Topotecan—lung cancer	0.000972	0.00315	CcSEcCtD
Bedaquiline—Chest pain—Topotecan—lung cancer	0.000972	0.00315	CcSEcCtD
Bedaquiline—Dermatitis—Gefitinib—lung cancer	0.000972	0.00315	CcSEcCtD
Bedaquiline—Hepatic enzyme increased—Methotrexate—lung cancer	0.000971	0.00315	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Paclitaxel—lung cancer	0.000962	0.00312	CcSEcCtD
Bedaquiline—Myalgia—Erlotinib—lung cancer	0.000962	0.00312	CcSEcCtD
Bedaquiline—Chest pain—Erlotinib—lung cancer	0.000962	0.00312	CcSEcCtD
Bedaquiline—Arthralgia—Erlotinib—lung cancer	0.000962	0.00312	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Gemcitabine—lung cancer	0.00095	0.00308	CcSEcCtD
Bedaquiline—Nausea—Pemetrexed—lung cancer	0.000922	0.00299	CcSEcCtD
Bedaquiline—Nausea—Gefitinib—lung cancer	0.000916	0.00297	CcSEcCtD
Bedaquiline—Anorexia—Vinblastine—lung cancer	0.000915	0.00297	CcSEcCtD
Bedaquiline—Nervous system disorder—Topotecan—lung cancer	0.000914	0.00297	CcSEcCtD
Bedaquiline—Connective tissue disorder—Irinotecan—lung cancer	0.00091	0.00295	CcSEcCtD
Bedaquiline—Nervous system disorder—Erlotinib—lung cancer	0.000904	0.00293	CcSEcCtD
Bedaquiline—Anorexia—Topotecan—lung cancer	0.000889	0.00288	CcSEcCtD
Bedaquiline—Connective tissue disorder—Gemcitabine—lung cancer	0.000886	0.00287	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Cisplatin—lung cancer	0.000885	0.00287	CcSEcCtD
Bedaquiline—Anorexia—Erlotinib—lung cancer	0.000879	0.00285	CcSEcCtD
Bedaquiline—Diarrhoea—Teniposide—lung cancer	0.00086	0.00279	CcSEcCtD
Bedaquiline—Cardiac disorder—Irinotecan—lung cancer	0.000859	0.00279	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Topotecan—lung cancer	0.000849	0.00275	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00084	0.00273	CcSEcCtD
Bedaquiline—Cardiac disorder—Gemcitabine—lung cancer	0.000837	0.00271	CcSEcCtD
Bedaquiline—Decreased appetite—Vinblastine—lung cancer	0.000834	0.00271	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Docetaxel—lung cancer	0.000833	0.0027	CcSEcCtD
Bedaquiline—Chest pain—Vinorelbine—lung cancer	0.000832	0.0027	CcSEcCtD
Bedaquiline—Myalgia—Vinorelbine—lung cancer	0.000832	0.0027	CcSEcCtD
Bedaquiline—Arthralgia—Vinorelbine—lung cancer	0.000832	0.0027	CcSEcCtD
Bedaquiline—Arrhythmia—Irinotecan—lung cancer	0.000827	0.00268	CcSEcCtD
Bedaquiline—Connective tissue disorder—Cisplatin—lung cancer	0.000826	0.00268	CcSEcCtD
Bedaquiline—Alanine aminotransferase increased—Docetaxel—lung cancer	0.000816	0.00265	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Etoposide—lung cancer	0.000811	0.00263	CcSEcCtD
Bedaquiline—Decreased appetite—Topotecan—lung cancer	0.00081	0.00263	CcSEcCtD
Bedaquiline—Arrhythmia—Gemcitabine—lung cancer	0.000806	0.00261	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Topotecan—lung cancer	0.000805	0.00261	CcSEcCtD
Bedaquiline—Decreased appetite—Erlotinib—lung cancer	0.000802	0.0026	CcSEcCtD
Bedaquiline—Vomiting—Teniposide—lung cancer	0.0008	0.00259	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Erlotinib—lung cancer	0.000796	0.00258	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Paclitaxel—lung cancer	0.000795	0.00258	CcSEcCtD
Bedaquiline—Rash—Teniposide—lung cancer	0.000793	0.00257	CcSEcCtD
Bedaquiline—Dermatitis—Teniposide—lung cancer	0.000792	0.00257	CcSEcCtD
Bedaquiline—Headache—Teniposide—lung cancer	0.000788	0.00256	CcSEcCtD
Bedaquiline—Nervous system disorder—Vinorelbine—lung cancer	0.000782	0.00254	CcSEcCtD
Bedaquiline—Cardiac disorder—Cisplatin—lung cancer	0.00078	0.00253	CcSEcCtD
Bedaquiline—Anorexia—Vinorelbine—lung cancer	0.00076	0.00247	CcSEcCtD
Bedaquiline—Arrhythmia—Cisplatin—lung cancer	0.000751	0.00244	CcSEcCtD
Bedaquiline—Nausea—Teniposide—lung cancer	0.000747	0.00242	CcSEcCtD
Bedaquiline—Connective tissue disorder—Paclitaxel—lung cancer	0.000742	0.00241	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000727	0.00236	CcSEcCtD
Bedaquiline—Cardiac disorder—Etoposide—lung cancer	0.000715	0.00232	CcSEcCtD
Bedaquiline—Cardiac disorder—Paclitaxel—lung cancer	0.000701	0.00227	CcSEcCtD
Bedaquiline—Decreased appetite—Vinorelbine—lung cancer	0.000693	0.00225	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000688	0.00223	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Methotrexate—lung cancer	0.00068	0.00221	CcSEcCtD
Bedaquiline—Arrhythmia—Paclitaxel—lung cancer	0.000674	0.00219	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Docetaxel—lung cancer	0.000674	0.00219	CcSEcCtD
Bedaquiline—Chest pain—Gemcitabine—lung cancer	0.000668	0.00217	CcSEcCtD
Bedaquiline—Myalgia—Gemcitabine—lung cancer	0.000668	0.00217	CcSEcCtD
Bedaquiline—Arthralgia—Gemcitabine—lung cancer	0.000668	0.00217	CcSEcCtD
Bedaquiline—Hepatic function abnormal—Doxorubicin—lung cancer	0.000661	0.00214	CcSEcCtD
Bedaquiline—Diarrhoea—Vinblastine—lung cancer	0.000657	0.00213	CcSEcCtD
Bedaquiline—Nervous system disorder—Irinotecan—lung cancer	0.000645	0.00209	CcSEcCtD
Bedaquiline—Hepatitis—Docetaxel—lung cancer	0.00064	0.00208	CcSEcCtD
Bedaquiline—Diarrhoea—Topotecan—lung cancer	0.000638	0.00207	CcSEcCtD
Bedaquiline—Dizziness—Vinblastine—lung cancer	0.000635	0.00206	CcSEcCtD
Bedaquiline—Diarrhoea—Erlotinib—lung cancer	0.000631	0.00205	CcSEcCtD
Bedaquiline—Connective tissue disorder—Docetaxel—lung cancer	0.000629	0.00204	CcSEcCtD
Bedaquiline—Nervous system disorder—Gemcitabine—lung cancer	0.000628	0.00204	CcSEcCtD
Bedaquiline—Anorexia—Irinotecan—lung cancer	0.000627	0.00203	CcSEcCtD
Bedaquiline—Myalgia—Cisplatin—lung cancer	0.000623	0.00202	CcSEcCtD
Bedaquiline—Dizziness—Topotecan—lung cancer	0.000616	0.002	CcSEcCtD
Bedaquiline—Anorexia—Gemcitabine—lung cancer	0.000611	0.00198	CcSEcCtD
Bedaquiline—Vomiting—Vinblastine—lung cancer	0.00061	0.00198	CcSEcCtD
Bedaquiline—Dizziness—Erlotinib—lung cancer	0.00061	0.00198	CcSEcCtD
Bedaquiline—Tamoxifen—CYP2A6—lung cancer	0.000603	0.142	CrCbGaD
Bedaquiline—Headache—Vinblastine—lung cancer	0.000601	0.00195	CcSEcCtD
Bedaquiline—Cardiac disorder—Docetaxel—lung cancer	0.000594	0.00193	CcSEcCtD
Bedaquiline—Vomiting—Topotecan—lung cancer	0.000593	0.00192	CcSEcCtD
Bedaquiline—Cerebrovascular accident—Doxorubicin—lung cancer	0.000589	0.00191	CcSEcCtD
Bedaquiline—Rash—Topotecan—lung cancer	0.000588	0.00191	CcSEcCtD
Bedaquiline—Dermatitis—Topotecan—lung cancer	0.000587	0.0019	CcSEcCtD
Bedaquiline—Vomiting—Erlotinib—lung cancer	0.000586	0.0019	CcSEcCtD
Bedaquiline—Nervous system disorder—Cisplatin—lung cancer	0.000586	0.0019	CcSEcCtD
Bedaquiline—Headache—Topotecan—lung cancer	0.000584	0.00189	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000584	0.00189	CcSEcCtD
Bedaquiline—Rash—Erlotinib—lung cancer	0.000582	0.00189	CcSEcCtD
Bedaquiline—Dermatitis—Erlotinib—lung cancer	0.000581	0.00188	CcSEcCtD
Bedaquiline—Headache—Erlotinib—lung cancer	0.000578	0.00187	CcSEcCtD
Bedaquiline—Decreased appetite—Irinotecan—lung cancer	0.000572	0.00185	CcSEcCtD
Bedaquiline—Arrhythmia—Docetaxel—lung cancer	0.000572	0.00185	CcSEcCtD
Bedaquiline—Chest pain—Etoposide—lung cancer	0.000571	0.00185	CcSEcCtD
Bedaquiline—Nausea—Vinblastine—lung cancer	0.00057	0.00185	CcSEcCtD
Bedaquiline—Anorexia—Cisplatin—lung cancer	0.000569	0.00185	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Irinotecan—lung cancer	0.000568	0.00184	CcSEcCtD
Bedaquiline—Toremifene—ABCB1—lung cancer	0.000562	0.132	CrCbGaD
Bedaquiline—Arthralgia—Paclitaxel—lung cancer	0.00056	0.00181	CcSEcCtD
Bedaquiline—Chest pain—Paclitaxel—lung cancer	0.00056	0.00181	CcSEcCtD
Bedaquiline—Myalgia—Paclitaxel—lung cancer	0.00056	0.00181	CcSEcCtD
Bedaquiline—Decreased appetite—Gemcitabine—lung cancer	0.000557	0.00181	CcSEcCtD
Bedaquiline—Nausea—Topotecan—lung cancer	0.000554	0.0018	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000553	0.00179	CcSEcCtD
Bedaquiline—Nausea—Erlotinib—lung cancer	0.000548	0.00178	CcSEcCtD
Bedaquiline—Diarrhoea—Vinorelbine—lung cancer	0.000546	0.00177	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000544	0.00176	CcSEcCtD
Bedaquiline—Tamoxifen—ABCG2—lung cancer	0.00054	0.127	CrCbGaD
Bedaquiline—Dizziness—Vinorelbine—lung cancer	0.000527	0.00171	CcSEcCtD
Bedaquiline—Nervous system disorder—Paclitaxel—lung cancer	0.000526	0.00171	CcSEcCtD
Bedaquiline—Anorexia—Etoposide—lung cancer	0.000521	0.00169	CcSEcCtD
Bedaquiline—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.00052	0.00169	CcSEcCtD
Bedaquiline—Decreased appetite—Cisplatin—lung cancer	0.000519	0.00168	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Cisplatin—lung cancer	0.000516	0.00167	CcSEcCtD
Bedaquiline—Anorexia—Paclitaxel—lung cancer	0.000511	0.00166	CcSEcCtD
Bedaquiline—CYP3A4—Codeine and Morphine Metabolism—ABCC3—lung cancer	0.00051	0.0459	CbGpPWpGaD
Bedaquiline—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000509	0.00165	CcSEcCtD
Bedaquiline—Vomiting—Vinorelbine—lung cancer	0.000507	0.00164	CcSEcCtD
Bedaquiline—Rash—Vinorelbine—lung cancer	0.000503	0.00163	CcSEcCtD
Bedaquiline—Dermatitis—Vinorelbine—lung cancer	0.000502	0.00163	CcSEcCtD
Bedaquiline—Headache—Vinorelbine—lung cancer	0.0005	0.00162	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000489	0.00159	CcSEcCtD
Bedaquiline—Hepatobiliary disease—Methotrexate—lung cancer	0.000486	0.00158	CcSEcCtD
Bedaquiline—CYP3A4—Codeine and Morphine Metabolism—UGT1A1—lung cancer	0.00048	0.0432	CbGpPWpGaD
Bedaquiline—Decreased appetite—Etoposide—lung cancer	0.000476	0.00154	CcSEcCtD
Bedaquiline—Chest pain—Docetaxel—lung cancer	0.000474	0.00154	CcSEcCtD
Bedaquiline—Arthralgia—Docetaxel—lung cancer	0.000474	0.00154	CcSEcCtD
Bedaquiline—Myalgia—Docetaxel—lung cancer	0.000474	0.00154	CcSEcCtD
Bedaquiline—Nausea—Vinorelbine—lung cancer	0.000474	0.00154	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Etoposide—lung cancer	0.000472	0.00153	CcSEcCtD
Bedaquiline—Decreased appetite—Paclitaxel—lung cancer	0.000466	0.00151	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000463	0.0015	CcSEcCtD
Bedaquiline—Hepatitis—Methotrexate—lung cancer	0.000461	0.0015	CcSEcCtD
Bedaquiline—Diarrhoea—Irinotecan—lung cancer	0.00045	0.00146	CcSEcCtD
Bedaquiline—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—lung cancer	0.00045	0.0405	CbGpPWpGaD
Bedaquiline—Nervous system disorder—Docetaxel—lung cancer	0.000446	0.00145	CcSEcCtD
Bedaquiline—Diarrhoea—Gemcitabine—lung cancer	0.000438	0.00142	CcSEcCtD
Bedaquiline—Dizziness—Irinotecan—lung cancer	0.000435	0.00141	CcSEcCtD
Bedaquiline—Anorexia—Docetaxel—lung cancer	0.000433	0.00141	CcSEcCtD
Bedaquiline—Tamoxifen—CYP2E1—lung cancer	0.000428	0.101	CrCbGaD
Bedaquiline—Cardiac disorder—Methotrexate—lung cancer	0.000428	0.00139	CcSEcCtD
Bedaquiline—Tamoxifen—CYP1A1—lung cancer	0.000423	0.0993	CrCbGaD
Bedaquiline—Hepatobiliary disease—Doxorubicin—lung cancer	0.000421	0.00136	CcSEcCtD
Bedaquiline—Vomiting—Irinotecan—lung cancer	0.000418	0.00136	CcSEcCtD
Bedaquiline—Orphenadrine—CYP2E1—lung cancer	0.000416	0.0978	CrCbGaD
Bedaquiline—Rash—Irinotecan—lung cancer	0.000415	0.00135	CcSEcCtD
Bedaquiline—Dermatitis—Irinotecan—lung cancer	0.000414	0.00134	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000414	0.00134	CcSEcCtD
Bedaquiline—Headache—Irinotecan—lung cancer	0.000412	0.00134	CcSEcCtD
Bedaquiline—Diarrhoea—Cisplatin—lung cancer	0.000409	0.00133	CcSEcCtD
Bedaquiline—Vomiting—Gemcitabine—lung cancer	0.000407	0.00132	CcSEcCtD
Bedaquiline—Rash—Gemcitabine—lung cancer	0.000404	0.00131	CcSEcCtD
Bedaquiline—Dermatitis—Gemcitabine—lung cancer	0.000404	0.00131	CcSEcCtD
Bedaquiline—Headache—Gemcitabine—lung cancer	0.000401	0.0013	CcSEcCtD
Bedaquiline—Hepatitis—Doxorubicin—lung cancer	0.000399	0.0013	CcSEcCtD
Bedaquiline—Decreased appetite—Docetaxel—lung cancer	0.000395	0.00128	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Docetaxel—lung cancer	0.000392	0.00127	CcSEcCtD
Bedaquiline—Connective tissue disorder—Doxorubicin—lung cancer	0.000392	0.00127	CcSEcCtD
Bedaquiline—Nausea—Irinotecan—lung cancer	0.000391	0.00127	CcSEcCtD
Bedaquiline—Nausea—Gemcitabine—lung cancer	0.000381	0.00123	CcSEcCtD
Bedaquiline—Vomiting—Cisplatin—lung cancer	0.00038	0.00123	CcSEcCtD
Bedaquiline—Rash—Cisplatin—lung cancer	0.000376	0.00122	CcSEcCtD
Bedaquiline—Dermatitis—Cisplatin—lung cancer	0.000376	0.00122	CcSEcCtD
Bedaquiline—Diarrhoea—Etoposide—lung cancer	0.000374	0.00121	CcSEcCtD
Bedaquiline—Cardiac disorder—Doxorubicin—lung cancer	0.000371	0.0012	CcSEcCtD
Bedaquiline—Diarrhoea—Paclitaxel—lung cancer	0.000367	0.00119	CcSEcCtD
Bedaquiline—Dizziness—Etoposide—lung cancer	0.000362	0.00117	CcSEcCtD
Bedaquiline—Arrhythmia—Doxorubicin—lung cancer	0.000357	0.00116	CcSEcCtD
Bedaquiline—Dizziness—Paclitaxel—lung cancer	0.000355	0.00115	CcSEcCtD
Bedaquiline—Nausea—Cisplatin—lung cancer	0.000355	0.00115	CcSEcCtD
Bedaquiline—Vomiting—Etoposide—lung cancer	0.000348	0.00113	CcSEcCtD
Bedaquiline—Rash—Etoposide—lung cancer	0.000345	0.00112	CcSEcCtD
Bedaquiline—Dermatitis—Etoposide—lung cancer	0.000345	0.00112	CcSEcCtD
Bedaquiline—Headache—Etoposide—lung cancer	0.000343	0.00111	CcSEcCtD
Bedaquiline—Arthralgia—Methotrexate—lung cancer	0.000342	0.00111	CcSEcCtD
Bedaquiline—Chest pain—Methotrexate—lung cancer	0.000342	0.00111	CcSEcCtD
Bedaquiline—Myalgia—Methotrexate—lung cancer	0.000342	0.00111	CcSEcCtD
Bedaquiline—Vomiting—Paclitaxel—lung cancer	0.000341	0.00111	CcSEcCtD
Bedaquiline—Rash—Paclitaxel—lung cancer	0.000338	0.0011	CcSEcCtD
Bedaquiline—Dermatitis—Paclitaxel—lung cancer	0.000338	0.0011	CcSEcCtD
Bedaquiline—Headache—Paclitaxel—lung cancer	0.000336	0.00109	CcSEcCtD
Bedaquiline—Nausea—Etoposide—lung cancer	0.000325	0.00105	CcSEcCtD
Bedaquiline—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.000324	0.0291	CbGpPWpGaD
Bedaquiline—Nervous system disorder—Methotrexate—lung cancer	0.000321	0.00104	CcSEcCtD
Bedaquiline—Nausea—Paclitaxel—lung cancer	0.000319	0.00103	CcSEcCtD
Bedaquiline—Anorexia—Methotrexate—lung cancer	0.000312	0.00101	CcSEcCtD
Bedaquiline—Diarrhoea—Docetaxel—lung cancer	0.000311	0.00101	CcSEcCtD
Bedaquiline—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.000307	0.0276	CbGpPWpGaD
Bedaquiline—Dizziness—Docetaxel—lung cancer	0.000301	0.000975	CcSEcCtD
Bedaquiline—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000299	0.000968	CcSEcCtD
Bedaquiline—Myalgia—Doxorubicin—lung cancer	0.000296	0.00096	CcSEcCtD
Bedaquiline—Chest pain—Doxorubicin—lung cancer	0.000296	0.00096	CcSEcCtD
Bedaquiline—Arthralgia—Doxorubicin—lung cancer	0.000296	0.00096	CcSEcCtD
Bedaquiline—Vomiting—Docetaxel—lung cancer	0.000289	0.000938	CcSEcCtD
Bedaquiline—Rash—Docetaxel—lung cancer	0.000287	0.00093	CcSEcCtD
Bedaquiline—Dermatitis—Docetaxel—lung cancer	0.000286	0.000929	CcSEcCtD
Bedaquiline—Decreased appetite—Methotrexate—lung cancer	0.000285	0.000924	CcSEcCtD
Bedaquiline—Headache—Docetaxel—lung cancer	0.000285	0.000924	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Methotrexate—lung cancer	0.000283	0.000918	CcSEcCtD
Bedaquiline—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.00028	0.0252	CbGpPWpGaD
Bedaquiline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000279	0.0251	CbGpPWpGaD
Bedaquiline—Nervous system disorder—Doxorubicin—lung cancer	0.000278	0.000903	CcSEcCtD
Bedaquiline—Anorexia—Doxorubicin—lung cancer	0.00027	0.000877	CcSEcCtD
Bedaquiline—Nausea—Docetaxel—lung cancer	0.00027	0.000876	CcSEcCtD
Bedaquiline—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.00027	0.0243	CbGpPWpGaD
Bedaquiline—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.000266	0.0239	CbGpPWpGaD
Bedaquiline—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.00026	0.0234	CbGpPWpGaD
Bedaquiline—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000258	0.000838	CcSEcCtD
Bedaquiline—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.000251	0.0226	CbGpPWpGaD
Bedaquiline—Decreased appetite—Doxorubicin—lung cancer	0.000247	0.0008	CcSEcCtD
Bedaquiline—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000245	0.000795	CcSEcCtD
Bedaquiline—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000225	0.0202	CbGpPWpGaD
Bedaquiline—Tamoxifen—ABCB1—lung cancer	0.000225	0.0528	CrCbGaD
Bedaquiline—Diarrhoea—Methotrexate—lung cancer	0.000224	0.000727	CcSEcCtD
Bedaquiline—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000217	0.0196	CbGpPWpGaD
Bedaquiline—Dizziness—Methotrexate—lung cancer	0.000217	0.000703	CcSEcCtD
Bedaquiline—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.00021	0.0189	CbGpPWpGaD
Bedaquiline—Vomiting—Methotrexate—lung cancer	0.000208	0.000676	CcSEcCtD
Bedaquiline—Rash—Methotrexate—lung cancer	0.000207	0.00067	CcSEcCtD
Bedaquiline—Dermatitis—Methotrexate—lung cancer	0.000206	0.00067	CcSEcCtD
Bedaquiline—Headache—Methotrexate—lung cancer	0.000205	0.000666	CcSEcCtD
Bedaquiline—Nausea—Methotrexate—lung cancer	0.000195	0.000631	CcSEcCtD
Bedaquiline—Diarrhoea—Doxorubicin—lung cancer	0.000194	0.00063	CcSEcCtD
Bedaquiline—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000191	0.0172	CbGpPWpGaD
Bedaquiline—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000188	0.0169	CbGpPWpGaD
Bedaquiline—Dizziness—Doxorubicin—lung cancer	0.000188	0.000609	CcSEcCtD
Bedaquiline—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000181	0.0163	CbGpPWpGaD
Bedaquiline—Vomiting—Doxorubicin—lung cancer	0.00018	0.000585	CcSEcCtD
Bedaquiline—Rash—Doxorubicin—lung cancer	0.000179	0.00058	CcSEcCtD
Bedaquiline—Dermatitis—Doxorubicin—lung cancer	0.000179	0.00058	CcSEcCtD
Bedaquiline—Headache—Doxorubicin—lung cancer	0.000178	0.000577	CcSEcCtD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000176	0.0159	CbGpPWpGaD
Bedaquiline—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000172	0.0155	CbGpPWpGaD
Bedaquiline—Nausea—Doxorubicin—lung cancer	0.000169	0.000547	CcSEcCtD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000168	0.0152	CbGpPWpGaD
Bedaquiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.00016	0.0144	CbGpPWpGaD
Bedaquiline—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.00016	0.0144	CbGpPWpGaD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000158	0.0142	CbGpPWpGaD
Bedaquiline—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000154	0.0138	CbGpPWpGaD
Bedaquiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000147	0.0132	CbGpPWpGaD
Bedaquiline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000142	0.0128	CbGpPWpGaD
Bedaquiline—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000137	0.0124	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000134	0.0121	CbGpPWpGaD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000133	0.0119	CbGpPWpGaD
Bedaquiline—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000132	0.0119	CbGpPWpGaD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000129	0.0116	CbGpPWpGaD
Bedaquiline—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000125	0.0112	CbGpPWpGaD
Bedaquiline—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.00012	0.0108	CbGpPWpGaD
Bedaquiline—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000115	0.0103	CbGpPWpGaD
Bedaquiline—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.00011	0.00994	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000109	0.0098	CbGpPWpGaD
Bedaquiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000105	0.00941	CbGpPWpGaD
Bedaquiline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	8.56e-05	0.00771	CbGpPWpGaD
Bedaquiline—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	8.21e-05	0.00739	CbGpPWpGaD
Bedaquiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	8.16e-05	0.00734	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	7.8e-05	0.00702	CbGpPWpGaD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	7.7e-05	0.00693	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	6.64e-05	0.00597	CbGpPWpGaD
Bedaquiline—CYP3A4—Tryptophan metabolism—CAT—lung cancer	6.59e-05	0.00593	CbGpPWpGaD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	6.55e-05	0.00589	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CNDP2—lung cancer	6.4e-05	0.00576	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTM2—lung cancer	6.4e-05	0.00576	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	6.33e-05	0.00569	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	6.31e-05	0.00568	CbGpPWpGaD
Bedaquiline—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	5.9e-05	0.00531	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP2A7—lung cancer	5.79e-05	0.00521	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	5.71e-05	0.00514	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	5.38e-05	0.00484	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTA3—lung cancer	5.16e-05	0.00464	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	5.09e-05	0.00458	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	4.77e-05	0.00429	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTA4—lung cancer	4.72e-05	0.00424	CbGpPWpGaD
Bedaquiline—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	4.7e-05	0.00423	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	4.65e-05	0.00419	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTA2—lung cancer	4.6e-05	0.00414	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTA1—lung cancer	4.43e-05	0.00399	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	4.19e-05	0.00377	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—UGT1A1—lung cancer	4.12e-05	0.00371	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	4.07e-05	0.00366	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	3.86e-05	0.00348	CbGpPWpGaD
Bedaquiline—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	3.64e-05	0.00327	CbGpPWpGaD
Bedaquiline—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	3.55e-05	0.0032	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—HPGDS—lung cancer	3.5e-05	0.00315	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTT1—lung cancer	3.4e-05	0.00306	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP2A6—lung cancer	3.36e-05	0.00302	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GCLC—lung cancer	3.36e-05	0.00302	CbGpPWpGaD
Bedaquiline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.88e-05	0.00259	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP2E1—lung cancer	2.86e-05	0.00257	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	2.82e-05	0.00254	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.36e-05	0.00212	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.32e-05	0.00209	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.17e-05	0.00195	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.14e-05	0.00192	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.05e-05	0.00185	CbGpPWpGaD
Bedaquiline—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.02e-05	0.00182	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—AZIN2—lung cancer	1.81e-05	0.00163	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—COL4A3BP—lung cancer	1.81e-05	0.00163	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ATP5H—lung cancer	1.54e-05	0.00138	CbGpPWpGaD
Bedaquiline—CYP3A4—Biological oxidations—POMC—lung cancer	1.53e-05	0.00138	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PLBD1—lung cancer	1.37e-05	0.00123	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—HSD17B10—lung cancer	1.25e-05	0.00113	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CKB—lung cancer	1.16e-05	0.00105	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CNDP2—lung cancer	1.09e-05	0.000985	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTM2—lung cancer	1.09e-05	0.000985	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—MTMR3—lung cancer	1.06e-05	0.000958	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PGAM1—lung cancer	1.04e-05	0.000933	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP2A7—lung cancer	9.89e-06	0.00089	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—SDC4—lung cancer	9.68e-06	0.000871	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—RRM1—lung cancer	8.82e-06	0.000794	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTA3—lung cancer	8.82e-06	0.000794	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—B4GALT5—lung cancer	8.29e-06	0.000746	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTA4—lung cancer	8.07e-06	0.000726	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTA2—lung cancer	7.86e-06	0.000707	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTA1—lung cancer	7.58e-06	0.000682	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ABCC3—lung cancer	7.5e-06	0.000675	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—AKR1C1—lung cancer	7.26e-06	0.000654	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—UGT1A1—lung cancer	7.05e-06	0.000634	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GNG11—lung cancer	6.8e-06	0.000612	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ALDOA—lung cancer	6.47e-06	0.000582	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NCOA3—lung cancer	6.28e-06	0.000565	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ADCY1—lung cancer	6.11e-06	0.00055	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ABCG2—lung cancer	6.11e-06	0.00055	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ENO2—lung cancer	5.99e-06	0.000539	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—HPGDS—lung cancer	5.99e-06	0.000539	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PPP2R1B—lung cancer	5.96e-06	0.000536	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTT1—lung cancer	5.81e-06	0.000523	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP2A6—lung cancer	5.75e-06	0.000517	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GCLC—lung cancer	5.75e-06	0.000517	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ENO1—lung cancer	5.45e-06	0.00049	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP2E1—lung cancer	4.89e-06	0.00044	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—NQO1—lung cancer	4.83e-06	0.000435	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—STK11—lung cancer	4.36e-06	0.000392	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTP1—lung cancer	4.03e-06	0.000363	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CAT—lung cancer	3.92e-06	0.000353	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ABCB1—lung cancer	3.81e-06	0.000343	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—TYMS—lung cancer	3.75e-06	0.000337	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—GSTM1—lung cancer	3.7e-06	0.000333	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CYP1A1—lung cancer	3.51e-06	0.000316	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ERCC2—lung cancer	3.48e-06	0.000313	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—APOA1—lung cancer	3.01e-06	0.000271	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PIK3CG—lung cancer	2.75e-06	0.000247	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—POMC—lung cancer	2.62e-06	0.000236	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—CREBBP—lung cancer	2.55e-06	0.000229	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PIK3CD—lung cancer	2.42e-06	0.000218	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—ALB—lung cancer	2.39e-06	0.000215	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PIK3CB—lung cancer	2.11e-06	0.00019	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PTGS2—lung cancer	2.09e-06	0.000188	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PTEN—lung cancer	1.82e-06	0.000164	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—EP300—lung cancer	1.74e-06	0.000156	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—PIK3CA—lung cancer	1.28e-06	0.000116	CbGpPWpGaD
Bedaquiline—CYP3A4—Metabolism—AKT1—lung cancer	1.05e-06	9.44e-05	CbGpPWpGaD
